1.Comparison of Proliferative Activity in Each Histological Subtypes of Benign and Atypical Intracranial Meningiomas by PCNA and Ki-67 Immunolabeling.
Seung Jin CHOI ; Eun Deok CHANG ; Seung Oh KWON ; Dae Kon KYE ; Choon Keun PARK ; Sang Won LEE ; Joon Ki KANG
Journal of Korean Neurosurgical Society 2000;29(9):1215-1221
No abstract available.
Meningioma*
;
Proliferating Cell Nuclear Antigen*
2.IMMUNOHISTOCHEMICAL STUDY OF Ki-67 AND PROLIFERATING CELL NUCLEAR ANTIGEN EXPRESSION IN MALIGNANT MELANOMA.
Won Sok HYON ; Kyung Won MINN ; Jae Jung KIM
Journal of the Korean Society of Plastic and Reconstructive Surgeons 1997;24(5):1044-1053
No abstract available.
Melanoma*
;
Proliferating Cell Nuclear Antigen*
4.Proliferating cell nuclear antigen and nucleolar organizer region in cervical intraepithetial neoplasia.
Chang Hong KIM ; Seung Kyu HWANG ; Gi Yeon HONG ; Heung Gon KIM ; Boo Ki MIN
Korean Journal of Obstetrics and Gynecology 1993;36(7):2328-2338
No abstract available.
Nucleolus Organizer Region*
;
Proliferating Cell Nuclear Antigen*
5.Proliferating cell nuclear antigen and nucleolar organizer region in cervical intraepithetial neoplasia.
Chang Hong KIM ; Seung Kyu HWANG ; Gi Yeon HONG ; Heung Gon KIM ; Boo Ki MIN
Korean Journal of Obstetrics and Gynecology 1993;36(7):2328-2338
No abstract available.
Nucleolus Organizer Region*
;
Proliferating Cell Nuclear Antigen*
6.Expression of proliferating cell nuclear antigen in lung cancer.
Sun Young KIM ; Kyung Joo LEE ; Suk Chul HONG ; Pyo Sung HAN ; Jong Jin LEE ; Hae Jung CHO ; Ju Ock KIM
Tuberculosis and Respiratory Diseases 1993;40(1):23-28
No abstract available.
Lung Neoplasms*
;
Lung*
;
Proliferating Cell Nuclear Antigen*
7.An immunohistochemical study on p53 and PCNA expression in gastric cancer related to survival and prognostic factors.
Seok Hwan LEE ; Young Gwan KO ; Suck Hwan KOH ; Soo Myung OH
Journal of the Korean Surgical Society 1993;45(5):781-791
No abstract available.
Proliferating Cell Nuclear Antigen*
;
Stomach Neoplasms*
8.The significance of DNA content, histological grades, cathepsin-D, and PCNA in advanced breast cancers.
Jeoung Won BAE ; Hee Sang KIM ; Cheung Wung WHANG
Journal of the Korean Surgical Society 1993;45(5):633-644
No abstract available.
Breast*
;
DNA*
;
Proliferating Cell Nuclear Antigen*
9.Prognostic Significance of Proliferating Cell Nuclear Antigen in Epithelial Ovarian Cancer.
Seung Hwa SHIN ; Joon Mo AHN ; Dong Hwi KIM ; Un Dong PARK
Korean Journal of Obstetrics and Gynecology 1997;40(12):2833-2839
No abstract available.
Ovarian Neoplasms*
;
Proliferating Cell Nuclear Antigen*
10.Proliferating Cell Nuclear Antigen : Relation to Histologic Grade and Prognosis.
Seung Hwa SHIN ; Eun Dong PARK
Korean Journal of Gynecologic Oncology and Colposcopy 1995;6(3):157-165
The measurement of tumor cell proliferation is becoming inueasingly recognized in defining prognostic groups. Boliferatirg cell nuclear antigen(PCNA) imrnunolocalimtion can be used as an index of cell proliferation and rnay define the extent of deppature from norrmil gmwth control. PCNA is eonsidered to be maker of cell proliferation. The aim of this study was to evnlunte the expreeion of PCNA in epithelial ocarian cancer as well as the possible correlation with degree of differentiation, tumor etage and overall survival. The material consisted of 35 epithehal ovarian cancer. The PCNA labelling index (Ll) ranged from 7.5% to 92.5% with a median value of 46.7%. PCNA labelling index (LI) is 30% in grade 1, 63% in grade 2, and 100% in grade 3 in epithelial ovarian cancer(p>0.05). Also, a positive correlation was found between PCNA labelling index (LI) and clinical stage (P<0.05) The estimated 3 year survival in patients with a tumor LI below the median (low proliferative group) was higher than those with a tumor LI greater than the median(high proliferation group) (87.5% VS 50%, P<0.05).
Cell Proliferation
;
Humans
;
Ovarian Neoplasms
;
Prognosis*
;
Proliferating Cell Nuclear Antigen*
Result Analysis
Print
Save
E-mail